{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T18:12:54Z","timestamp":1769019174180,"version":"3.49.0"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,20]],"date-time":"2021-06-20T00:00:00Z","timestamp":1624147200000},"content-version":"vor","delay-in-days":170,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Treatment and Research Communications"],"published-print":{"date-parts":[[2021]]},"DOI":"10.1016\/j.ctarc.2021.100427","type":"journal-article","created":{"date-parts":[[2021,6,26]],"date-time":"2021-06-26T03:56:51Z","timestamp":1624679811000},"page":"100427","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Autologous dendritic cell-based immunotherapy (DCVAC\/LuCa) and carboplatin\/paclitaxel in advanced non-small cell lung cancer: A randomized, open-label, phase I\/II trial"],"prefix":"10.1016","volume":"28","author":[{"given":"Milada","family":"Zemanova","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marketa","family":"Cernovska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Libor","family":"Havel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomas","family":"Bartek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarka","family":"Lukesova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jitka","family":"Jakesova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaroslav","family":"Vanasek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pavel","family":"Reiterer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juraj","family":"Kultan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Igor","family":"Andrasina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lenka","family":"Siskova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leona","family":"Koubkova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jana","family":"Skrickova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frantisek","family":"Salajka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Milos","family":"Pesek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Petr","family":"Klepetko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juraj","family":"Beniak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harald","family":"Fricke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pavla","family":"Kadlecova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roman P.","family":"Korolkiewicz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marek","family":"Hraska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jirina","family":"Bartunkova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Radek","family":"Spisek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ctarc.2021.100427_bib0001","first-page":"9","article-title":"Cancer statistics","volume":"64","author":"Siegel","year":"2016","journal-title":"CA Cancer J Clin."},{"key":"10.1016\/j.ctarc.2021.100427_bib0002","article-title":"Lung cancer incidence trends by gender, race and histology in the United States,","volume":"10","author":"Meza","year":"2016","journal-title":"PLoS ONE"},{"key":"10.1016\/j.ctarc.2021.100427_bib0003","first-page":"11","article-title":"Cancer statistics","volume":"63","author":"Siegel","year":"2013","journal-title":"CA Cancer J Clin."},{"key":"10.1016\/j.ctarc.2021.100427_bib0004","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1056\/NEJMoa1507643","article-title":"Nivolumab versus docetaxel in advanced nonsquamous non-small-cell lung cancer","volume":"373","author":"Borghaei","year":"2015","journal-title":"N Engl J Med."},{"key":"10.1016\/j.ctarc.2021.100427_bib0005","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1056\/NEJMoa1501824","article-title":"Pembrolizumab for the treatment of non-small-cell lung cancer","volume":"372","author":"Garon","year":"2015","journal-title":"N Engl J Med."},{"key":"10.1016\/j.ctarc.2021.100427_bib0006","doi-asserted-by":"crossref","first-page":"12472","DOI":"10.18632\/oncotarget.2998","article-title":"Classification of current anticancer immunotherapies","volume":"5","author":"Galluzzi","year":"2014","journal-title":"Oncotarget"},{"key":"10.1016\/j.ctarc.2021.100427_bib0007","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1097\/PPO.0000000000000489","article-title":"What is the standard first-line treatment for advanced non-small cell lung cancer?","volume":"26","author":"Ricciuti","year":"2020","journal-title":"Cancer J."},{"key":"10.1016\/j.ctarc.2021.100427_bib0008","doi-asserted-by":"crossref","first-page":"5384","DOI":"10.1158\/1078-0432.CCR-14-1298","article-title":"Cisplatin-induced antitumor immunomodulation: a review of preclinical and clinical evidence","volume":"20","author":"de Biasi","year":"2014","journal-title":"Clin Cancer Res."},{"key":"10.1016\/j.ctarc.2021.100427_bib0009","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1158\/0008-5472.CAN-15-1142","article-title":"Calreticulin expression in human non-small cell lung cancers correlates with increased accumulation of antitumor immune cells and favorable prognosis","volume":"76","author":"Fucikova","year":"2016","journal-title":"Cancer Res."},{"key":"10.1016\/j.ctarc.2021.100427_bib0010","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41577-019-0210-z","article-title":"Dendritic cells in cancer immunology and immunotherapy","volume":"20","author":"Wculek","year":"2020","journal-title":"Nat Rev Immunol."},{"key":"10.1016\/j.ctarc.2021.100427_bib0011","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s00262-017-2068-x","article-title":"Phase I\/II trial of dendritic cell-based active cellular immunotherapy with DCVAC\/PCa in patients with rising PSA after primary prostatectomy or salvage radiotherapy for the treatment of prostate cancer","volume":"67","author":"Fucikova","year":"2018","journal-title":"Cancer Immunol Immunother."},{"key":"10.1016\/j.ctarc.2021.100427_bib0012","doi-asserted-by":"crossref","first-page":"18192","DOI":"10.18632\/oncotarget.4145","article-title":"Phase I\/II clinical trial of dendritic-cell based immunotherapy (DCVAC\/PCa) combined with chemotherapy in patients with metastatic, castration-resistant prostate cancer","volume":"6","author":"Podrazil","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.ctarc.2021.100427_bib0013","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.3389\/fimmu.2019.02393","article-title":"Induction of tolerance and immunity by dendritic cells: mechanisms and clinical applications","volume":"10","author":"Fucikova","year":"2019","journal-title":"Front Immunol."},{"key":"10.1016\/j.ctarc.2021.100427_bib0014","doi-asserted-by":"crossref","DOI":"10.4161\/21624011.2014.968434","article-title":"Physical modalities inducing immunogenic tumor cell death for cancer immunotherapy","volume":"3","author":"Adkins","year":"2014","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.ctarc.2021.100427_bib0015","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0171539","article-title":"Generation of dendritic cell-based vaccine using high hydrostatic pressure for non-small cell lung cancer immunotherapy","volume":"12","author":"Hradilova","year":"2017","journal-title":"PLoS ONE"},{"key":"10.1016\/j.ctarc.2021.100427_bib0016","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.imlet.2017.05.005","article-title":"High hydrostatic pressure affects antigenic pool in tumor cells: implication for dendritic cell-based cancer immunotherapy","volume":"187","author":"Urbanova","year":"2017","journal-title":"Immunol Lett."},{"key":"10.1016\/j.ctarc.2021.100427_bib0017","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.imlet.2020.01.001","article-title":"Detection of tumor antigens and tumor-antigen specific T cells in NSCLC patients: correlation of the quality of T cell responses with NSCLC subtype","volume":"219","author":"Palata","year":"2020","journal-title":"Immunol Lett."},{"key":"10.1016\/j.ctarc.2021.100427_bib0018","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1002\/ijc.28766","article-title":"High hydrostatic pressure induces immunogenic cell death in human tumor cells","volume":"135","author":"Fucikova","year":"2014","journal-title":"Int J Cancer."},{"key":"10.1016\/j.ctarc.2021.100427_bib0019","unstructured":"Common terminology criteria for adverse events (version 4.0). https:\/\/www.eortc.be\/services\/doc\/ctc\/CTCAE_4.03_2010-06-14_QuickReference_5x7.pdf. Accessed January 6, 2021."},{"key":"10.1016\/j.ctarc.2021.100427_bib0020","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.1056\/NEJMoa061884","article-title":"Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer","volume":"355","author":"Sandler","year":"2006","journal-title":"N Engl J Med."},{"key":"10.1016\/j.ctarc.2021.100427_bib0021","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1200\/JCO.2004.07.215","article-title":"Gefitinib in combination with paclitaxel and carboplatin in advanced non-small-cell lung cancer: a phase III trial\u2013INTACT 2","volume":"22","author":"Herbst","year":"2004","journal-title":"J Clin Oncol."},{"key":"10.1016\/j.ctarc.2021.100427_bib0022","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.1016\/j.ejca.2015.07.035","article-title":"A phase III study of belagenpumatucel-L, an allogeneic tumour cell vaccine, as maintenance therapy for non-small cell lung cancer","volume":"51","author":"Giaccone","year":"2015","journal-title":"Eur J Cancer."},{"key":"10.1016\/j.ctarc.2021.100427_bib0023","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S1470-2045(13)70510-2","article-title":"Tecemotide (L-BLP25) versus placebo after chemoradiotherapy for stage III non-small-cell lung cancer (START): a randomised, double-blind, phase 3 trial","volume":"15","author":"Butts","year":"2014","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ctarc.2021.100427_bib0024","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/S1470-2045(16)00099-1","article-title":"Efficacy of the MAGE-A3 cancer immunotherapeutic as adjuvant therapy in patients with resected MAGE-A3-positive non-small-cell lung cancer (MAGRIT): a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"17","author":"Vansteenkiste","year":"2016","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ctarc.2021.100427_bib0025","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s00262-017-2068-x","article-title":"Phase I\/II trial of dendritic cell-based active cellular immunotherapy with DCVAC\/PCa in patients with rising PSA after primary prostatectomy or salvage radiotherapy for the treatment of prostate cancer","volume":"67","author":"Fucikova","year":"2018","journal-title":"Cancer Immunol Immunother."},{"key":"10.1016\/j.ctarc.2021.100427_bib0026","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1038\/s41419-020-03221-2","article-title":"Detection of immunogenic cell death and its relevance for cancer therapy","volume":"11","author":"Fucikova","year":"2020","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ctarc.2021.100427_bib0027","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/s41422-020-0383-9","article-title":"Calreticulin and cancer","volume":"31","author":"Fucikova","year":"2021","journal-title":"Cell Res."},{"key":"10.1016\/j.ctarc.2021.100427_bib0028","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2019.1703449","article-title":"Trial watch: chemotherapy-induced immunogenic cell death in immuno-oncology","volume":"9","author":"Vanmeerbeek","year":"2020","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.ctarc.2021.100427_bib0029","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/bs.ircmb.2016.09.003","article-title":"Rationale for the combination of dendritic cell-based vaccination approaches with chemotherapy agents","volume":"330","author":"Truxova","year":"2017","journal-title":"Int Rev Cell Mol Biol."},{"key":"10.1016\/j.ctarc.2021.100427_bib0030","unstructured":"European Society for Medical Oncology. Metastatic non-small-cell lung cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. 2020; https:\/\/www.esmo.org\/guidelines\/lung-and-chest-tumours\/clinical-practice-living-guidelines-metastatic-non-small-cell-lung-cancer. Accessed January 6, 2021."},{"key":"10.1016\/j.ctarc.2021.100427_bib0031","unstructured":"Decision Resources Group. Current treatment: Physician insights, non-small cell lung cancer (EU5). 2020; https:\/\/decisionresourcesgroup.com\/research-reports\/biopharma\/non-small-cell-lung-cancer\/. Accessed January 6, 2021."}],"container-title":["Cancer Treatment and Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468294221001258?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468294221001258?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T06:18:40Z","timestamp":1762841920000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468294221001258"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021]]},"references-count":31,"alternative-id":["S2468294221001258"],"URL":"https:\/\/doi.org\/10.1016\/j.ctarc.2021.100427","relation":{},"ISSN":["2468-2942"],"issn-type":[{"value":"2468-2942","type":"print"}],"subject":[],"published":{"date-parts":[[2021]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Autologous dendritic cell-based immunotherapy (DCVAC\/LuCa) and carboplatin\/paclitaxel in advanced non-small cell lung cancer: A randomized, open-label, phase I\/II trial","name":"articletitle","label":"Article Title"},{"value":"Cancer Treatment and Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctarc.2021.100427","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100427"}}